Private Equity Firm Healthcare

Arsenal Capital Partners

New York, New York, United States

Arsenal is a private equity firm specializing in investments in middle-market industrial growth and healthcare companies, working with management teams to build strategically important, market-leading businesses.

Focus Areas
Middle-market industrial growth, Healthcare companies

Tracked deals

58

58 tracked deals across 2015-2026.

Recent pace

3

3 tracked deals announced in the last 12 months.

Deal mix

Addon

34 addon · 19 buyout · 2 growth capital

Arsenal Capital Partners Acquisition Volume by Year

Last 9 years

Acquisition volume by year Annual acquisition counts for the last 9 years for Arsenal Capital Partners. 1 2017 1 2018 13 2019 6 2020 17 2021 9 2022 5 2024 4 2025 ~2 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

Showing the 12 most recent of 58 tracked deals for Arsenal Capital Partners.

  • Buyer
    Arsenal Capital Partners
    Target
    Velcro Companies
    Seller
    Cripps Foundation
    Type
    Buyout

    Arsenal Capital Partners has agreed to acquire a majority stake in Velcro Companies from the Cripps Foundation. Arsenal will become the majority owner, while the Cripps Foundation will retain a significant minority stake; financial terms were not disclosed and the deal is expected to close in Q4 2026 subject to regulatory approvals.

  • Buyer
    Arsenal Capital Partners
    Target
    ThermoSafe
    Seller
    Sonoco Products Company
    Type
    Buyout

    Arsenal Capital Partners completed its acquisition of ThermoSafe, a temperature-assurance packaging business, from Sonoco Products Company. The deal was originally announced as a signed definitive agreement in September 2025 with a total purchase price of up to $725 million, including performance-based additional consideration.

  • Buyer
    Polycorp, Arsenal Capital Partners
    Target
    Burke Industries Inc.
    Seller
    Mannington Mills, Inc.
    Industry
    Manufacturing
    Type
    Addon

    Polycorp, a portfolio company of Arsenal Capital Partners, has acquired Burke Industries Inc. from Mannington Mills. The deal expands Polycorp's manufacturing footprint and technical capabilities in engineered elastomeric solutions, while Mannington will continue to manufacture Burke rubber flooring products at its Florida and Georgia facilities.

  • Buyer
    Knowtion Health, Arsenal Capital Partners, Sunstone Partners
    Target
    Switch RCM
    Type
    Addon

    Knowtion Health, a Boca Raton-based, PE-backed revenue cycle management provider, has completed the acquisition of Switch RCM, a data- and technology-first healthcare revenue intelligence firm based in Madison. The deal expands Knowtion’s automation, analytics and recovery capabilities and brings multiple Switch leaders into Knowtion’s executive and innovation teams; terms were not disclosed.

  • Buyer
    Headwall Group, Arsenal Capital Partners
    Target
    EVK DI Kerschhaggl GmbH
    Location
    Styria, Austria
    Type
    Addon

    Headwall Group, a Bolton, Massachusetts-based portfolio company of Arsenal Capital Partners, has acquired Austria-based EVK DI Kerschhaggl GmbH (EVK), a developer of industrial sensor-based sorting and inspection systems. The acquisition expands Headwall's hyperspectral imaging and sensor capabilities to better serve markets such as food processing, plastics recycling, and material sorting.

  • Buyer
    Arsenal Capital Partners, Sunstone Partners
    Target
    Knowtion Health
    Seller
    Sunstone Partners
    Type
    Buyout

    Arsenal Capital Partners has signed a definitive agreement to acquire Knowtion Health, a provider of AI-enabled revenue cycle and insurance claim resolution services. Sunstone Partners, the current majority owner, will remain a strategic co-investor; financial terms were not disclosed.

  • Buyer
    Arsenal Capital Partners, BayPine LP
    Target
    Poly-Wood, LLC (POLYWOOD)
    Seller
    Mayfair Capital Partners (Oxford Financial Group)
    Industry
    Manufacturing
    Type
    Buyout

    An investor group led by Arsenal Capital Partners, in partnership with BayPine LP, has acquired Poly-Wood, LLC (POLYWOOD) from Mayfair Capital Partners (a division of Oxford Financial Group). POLYWOOD is a vertically integrated manufacturer of recycled HDPE outdoor living products headquartered in Syracuse, Indiana, employing about 1,650 people; Arsenal and BayPine plan to invest in organic and inorganic growth and further develop the company's digital capabilities.

  • Buyer
    Arsenal Capital Partners
    Target
    Endpoint Clinical, Fortrea Patient Access
    Seller
    Fortrea

    Arsenal Capital Partners has acquired Fortrea's Endpoint Clinical and Fortrea Patient Access businesses in a divestiture completed June 4, 2024. The sale allows Fortrea to sharpen its focus as a pure‑play CRO while Arsenal will position Endpoint and the Patient Access business for accelerated investment and growth under management led by Sam Osman.

  • Buyer
    Arsenal Capital Partners
    Target
    Polycorp Ltd.
    Industry
    Manufacturing
    Location
    Ontario, Canada
    Type
    Buyout

    Arsenal Capital Partners completed a majority investment in Polycorp Ltd., a Canadian manufacturer of engineered elastomer solutions. Terms were not disclosed; Polycorp (headquartered in Elora, Ontario) employs ~250 people and founder Peter Snucins will remain an investor and board member as the company pursues manufacturing, R&D and strategic growth initiatives.

  • Buyer
    Headwall Photonics, Inc., Arsenal Capital Partners
    Target
    inno-spec GmbH
    Industry
    Manufacturing
    Location
    Bavaria, Germany
    Type
    Addon

    Headwall Photonics, a Bolton, Massachusetts-based portfolio company of Arsenal Capital Partners, has acquired inno-spec GmbH of Nuremberg, Germany. The add-on expands Headwall's industrial hyperspectral imaging capabilities for high-volume recycling, industrial sorting and quality-testing applications and aims to integrate inno-spec's industrial solutions with Headwall's optical components and remote-sensing technologies.

  • Buyer
    Arsenal Capital Partners
    Target
    Certara, Inc.
    Seller
    Funds controlled by EQT Private Equity
    Industry
    Biotechnology

    Arsenal Capital Partners closed a previously announced $449 million stock purchase in Certara, acquiring shares from funds controlled by EQT Private Equity and becoming a long-term minority investor. As part of the transaction Arsenal appointed Operating Partner David Spaight to Certara's board while Stephen McLean remains a director; Arsenal agreed to a two-year lock-up on the newly purchased shares.

  • Buyer
    Lumanity, Arsenal Capital Partners
    Target
    Clarion Healthcare
    Seller
    Svoboda Capital Partners
    Type
    Addon

    Lumanity, a portfolio company of Arsenal Capital Partners, has acquired Boston-based life sciences consultancy Clarion Healthcare from Svoboda Capital Partners. The undisclosed transaction expands Lumanity’s U.S. commercialization and product lifecycle consulting capabilities and creates greater global scale for life sciences strategy services.

Related Acquisition Pages

Selling a company? Get in front of buyers like Arsenal Capital Partners

Turn tracked acquisition activity into an outreach-ready buyer list.